LITSLite Strategy
Lite Strategy, Inc. (Nasdaq: LITS) is a pharmaceutical company that has historically developed novel and differentiated cancer therapies. 10-K, Item 1
- Headquarters
- San Diego, CA
- CEO
- Justin J. File
- Next results
- around Feb 16, 2027
Numbers in LITS's annual reports that a later 10-K reports differently for the same year and the same XBRL line item, fiscal years since 2020, changes of 0.5% or more. A change is a restatement (the company says the earlier number was wrong, in an 8-K item 4.02) or a recast: after selling a business, adopting an accounting rule or moving amounts between lines, companies redo past years. The later 10-K's notes say which.
| Number | Period | First reported | Later reported | Change | Why |
|---|---|---|---|---|---|
| Net income NetIncomeLoss · link |
Fiscal year ending 2024-06-30 | $17.78M 10-K filed 2024-09-19 |
$18.00M 10-K filed 2026-09-28 |
+1.2% | Recast or revision |
| Net income NetIncomeLoss · link |
Fiscal year ending 2023-06-30 | -$31.84M 10-K filed 2023-09-26 |
-$32.00M 10-K/A filed 2023-10-27 |
-0.5% | Recast or revision |
| Net income NetIncomeLoss · link |
Fiscal year ending 2023-06-30 | -$31.84M 10-K filed 2023-09-26 |
-$31.84M 10-K filed 2024-09-19 |
+0.0% | Recast or revision |
| Net income NetIncomeLoss · link |
Fiscal year ending 2023-06-30 | -$31.84M 10-K filed 2023-09-26 |
-$32.00M 10-K filed 2025-09-26 |
-0.5% | Recast or revision |
| Net income NetIncomeLoss · link |
Fiscal year ending 2022-06-30 | -$54.45M 10-K filed 2022-09-08 |
-$54.00M 10-K/A filed 2023-10-27 |
+0.8% | Recast or revision |
| Revenue Revenues · link |
Fiscal year ending 2021-06-30 | $25.54M 10-K filed 2021-09-02 |
$34.80M 10-K/A filed 2022-05-23 |
+36.3% | Restatement 8-K item 4.02, 2022-05-13 |
| Operating income OperatingIncomeLoss · link |
Fiscal year ending 2021-06-30 | -$69.69M 10-K filed 2021-09-02 |
-$60.42M 10-K/A filed 2022-05-23 |
+13.3% | Restatement 8-K item 4.02, 2022-05-13 |
| Net income NetIncomeLoss · link |
Fiscal year ending 2021-06-30 | -$50.58M 10-K filed 2021-09-02 |
-$41.31M 10-K/A filed 2022-05-23 |
+18.3% | Restatement 8-K item 4.02, 2022-05-13 |
| Net income NetIncomeLoss · link |
Fiscal year ending 2021-06-30 | -$50.58M 10-K filed 2021-09-02 |
-$41.00M 10-K/A filed 2023-10-27 |
+18.9% | Recast or revision |
| Shareholders' equity StockholdersEquity · link |
At 2021-06-30 | $41.36M 10-K filed 2021-09-02 |
$49.47M 10-K/A filed 2022-05-23 |
+19.6% | Restatement 8-K item 4.02, 2022-05-13 |
From SEC's XBRL company facts (8 10-K filings). Checked: revenue, operating income, net income, cash from operations, total assets, shareholders' equity, receivables and inventory. Per-share numbers are left out because stock splits change them.
Work on LITS in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/LITS/export.csv") into a cell.